Thermo Fisher Scientific Inc (TMO)
$469.44
$-3.19
(-0.67%)
As on 17-Jun-2026 13:47EDT
Market cap
$176,765 Mln
Revenue (TTM)
$45,197 Mln
P/E Ratio
26.2
P/B Ratio
3.4
Div. Yield
0.4 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$5,197 Mln
-
ROE
0.1 %
-
ROCE
7.6 %
-
Industry P/E
50.52
-
EV/EBITDA
18.5
-
Debt to Equity
0.8
-
Book Value
$--
-
EPS
$18.2
-
Face value
--
-
Shares outstanding
371,621,465
10 Years Aggregate
CFO
$57,505.80 Mln
EBITDA
$71,539.20 Mln
Net Profit
$41,795.60 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Thermo Fisher Scientific (TMO)
| -19.0 | 7.1 | -0.1 | 15.9 | -4.4 | 0.0 | 12.3 |
|
BSE Sensex
| -8.9 | 2.5 | 2.2 | -5.7 | 6.8 | 8.0 | 11.3 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Thermo Fisher Scientific (TMO)
| 11.4 | -2.0 | -3.6 | -17.5 | 43.5 | 43.7 | 45.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Thermo Fisher Scientific (TMO)
|
469.4 | 176,765.5 | 45,197.0 | 6,859.0 | 19.2 | 13.3 | 26.2 | 3.4 |
| 89.1 | 153,593.1 | 45,134.0 | 6,276.0 | 15.4 | 12.2 | 24.7 | 3.0 | |
| 142.9 | 40,295.0 | 21,365.0 | 1,138.0 | 9.9 | 4.6 | 25.5 | 1.7 | |
| 45.8 | 70,111.4 | 20,615.0 | 3,553.0 | 19.9 | 14.5 | 19.7 | 2.8 | |
| 180.0 | 127,957.8 | 24,778.0 | 3,689.0 | 18.5 | 7.1 | 35.1 | 2.4 | |
| 88.6 | 49,006.3 | 6,303.5 | 1,092.8 | 12.7 | 10.6 | 46 | 4.8 | |
| 561.0 | 44,243.9 | 4,446.1 | 1,095.2 | 31.7 | 70.3 | 41.3 | 28.4 | |
| 411.2 | 145,582.2 | 10,582.1 | 2,979.1 | 25.0 | 17.2 | 50 | 8.3 | |
| 79.2 | 103,134.5 | 36,364.0 | 4,800.0 | 13.3 | 19.6 | 21.5 | 2.1 | |
| 303.6 | 117,170.4 | 25,270.0 | 3,337.0 | 18.7 | 15.1 | 35.3 | 5.1 |
Shareholding Pattern
View DetailsAbout Thermo Fisher Scientific (TMO)
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four... segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts. Read more
-
Chairman, President & CEO
Mr. Marc N. Casper
-
Chairman, President & CEO
Mr. Marc N. Casper
-
Headquarters
Waltham, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Thermo Fisher Scientific (TMO)
What is the current share price of Thermo Fisher Scientific Inc (TMO) Today?
The share price of Thermo Fisher Scientific Inc (TMO) is $469.44 (NYSE) as of 17-Jun-2026 13:47 EDT. Thermo Fisher Scientific Inc (TMO) has given a return of -4.4% in the last 3 years.
What is the current PB & PE ratio of Thermo Fisher Scientific Inc (TMO)?
The P/E ratio of Thermo Fisher Scientific Inc (TMO) is 26.18 times as on 12-Jun-2026, a 48 discount to its peers’ median range of 50.52 times.
The P/B ratio of Thermo Fisher Scientific Inc (TMO) is 3.40 times as on 12-Jun-2026, a 1 premium to its peers’ median range of 3.37 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
32.43
|
4.09
|
|
2024
|
31.45
|
4.02
|
|
2023
|
34.35
|
4.41
|
|
2022
|
31.14
|
4.92
|
|
2021
|
34.38
|
6.51
|
What is the 52 Week High and Low of Thermo Fisher Scientific Inc (TMO)?
The 52-week high and low of Thermo Fisher Scientific Inc (TMO) are Rs 643.99 and Rs 385.46 as of 17-Jun-2026.
What is the market cap of Thermo Fisher Scientific Inc (TMO)?
Thermo Fisher Scientific Inc (TMO) has a market capitalisation of $ 176,765 Mln as on 12-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Thermo Fisher Scientific Inc (TMO)?
Before investing in Thermo Fisher Scientific Inc (TMO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.